Prion-specific peptide reagents

Details for Australian Patent Application No. 2009225337 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Hu, Celine; Zuckermann, Ronald N.; Connoly, Michael D.; Michelitsch, Melissa D.

Agent FB Rice

Pub. Number AU-A-2009225337

Parent 2004264953

Filing date 14 October 2009

Wipo publication date 5 November 2009

International Classifications

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

C07H 23/00 (2006.01) Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

G01N 33/536 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with immune complex formed in liquid phase

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

29 October 2009 Complete Application Filed

5 November 2009 Application Open to Public Inspection

  Published as AU-A-2009225337

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225338-An adjustable roof platform support device

2009225336-Method of compositing variable alpha fills supporting group opacity